Home About Us Contact Us

 

Table of Content - Volume 20 Issue 3 - December 2021


 

An observational study of pulmonary screening in rheumatoid arthritis patients at a tertiary hospital

 

Arsh Kumar Garg1*, Avneet Garg2

 

1Associate Professor, 2Assistant Professor, Department of Respiratory Medicine, Adesh Institute of Medical Sciences, Bathinda, INDIA.

Email: doctorarsh67@gmail.com

 

REFERENCES

 

  1. Shah A, St Clair EW. Rheumatoid arthritis. In: Dan LL, Anthony FS, Dennis KL, Stephen HL, Larry JJ, Joseph L, editors. Harrison’s Principles of Internal Medicine. 18th ed., Vol. 2. New Delhi: McGraw Hill Medical; 2012. p. 2745.
  2. Kim EJ, Collard HR, King Jr TE. Rheumatoid arthritis-associated interstitial lung disease. Chest 2009;136(5):1397–405.
  3. Kelly CA, Saravanan V, Nisar M, Arthanari S, Woodhead FA, Price-Forbes AN, Dawson J, Sathi N, Ahmad Y, Koduri G, Young A. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics–a large multicentre UK study. Rheumatology 2014;53(9):1676–82.
  4. B. R. Gochuico, N. A. Avila, C. K. Chow, L. J. Novero, H. P. Wu, P. Ren, S. D. MacDonald, W. D. Travis, M. P. Stylianou and I. O. Rosas, “Progressive Preclinical Interstitial Lung Disease in Rheumatoid Arthritis,” Archives of Internal Medicine, 168(2), 2008, pp. 159-166.
  5. V. Saravanan and C. A. Kelly, “Reducing the Risk of Methotrexate Pneumonitis in Rheumatoid Arthritis,” Rheumatology (Oxford), Vol. 43, No. 2, 2004, pp. 143-147.
  6. C. Kelly and V. Saravanan, “Treatment Strategies for a Rheumatoid Arthritis Patient with Interstitial Lung Disease,” Expert Opinion on Pharmacotherapy, 9 (18), 2008, pp. 3221-3230.
  7. Geuskens GA, Burdorf A, Hazes JM. Consequences of rheumatoid arthritis for performance of social roles--a literature review. J Rheumatol. 2007;34:1248-60.
  8. Robles-Perez, A. et al. Preclinical lung disease in early rheumatoid arthritis. Chron. Respir. Dis. 13, 75–81 (2016).
  9. Zhu, J., Zhou, Y., Chen, X. and Li, J. A metaanalysis of the increased risk of rheumatoid arthritis-related pulmonary disease as a result of serum anticitrullinated protein antibody positivity. J. Rheumatol. 41, 1282–1289 (2014).
  10. Sparks, J. A. et al. Rheumatoid arthritis disease activity predicting incident clinically apparent rheumatoid arthritis-associated interstitial lung disease: a prospective cohort study. Arthritis Rheumatol. 71, 1472–1482 (2019).
  11. Shaw M, Collins BF, Ho LA, Raghu G Rheumatoid arthritis-associated lung disease. ERR 2015, 24: 1-16.
  12. Assayag D, Lee JS, King TE, Rheumatoid arthritis associated interstitial lung disease: A review. Medicina 2014, 74:158-165.
  13. Rocha Muñoz AD, Ponce Guarneros M, Gamez Nava JI, Olivas Flores EM, Mejía M, et al. Anti-cyclic citrullinated peptide antibodies and severity of interstitial lung disease in women with rheumatoid arthritis. J Immunol Res 2015: 151626.
  14. Iqbal K, Kelly C. Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review. Ther Adv Musculoskelet Dis. 2015;7(6):247-267.
  15. Ganga B, Ahamed S, Krishna GG. Need for pulmonary screening in rheumatoid arthritis patients: An observational study. Indian J Respir Care 2020;9:186-90.
  16. Banotra P, Wangnoo A, Sharma M et.al. Study of the pulmonary manifestations in patients with rheumatoid arthritis. International Journal of Research and Review. 2020; 7(4): 427-436.
  17. Fatima N, Shameem M, Malik A, Khan PA, Shujatullah F, Ahmed S, andnbsp N. A Study on the Pulmonary Manifestations of Rheumatoid Arthritis from a North Indian Town. OJRD 2013;03(03):128–31.
  18. Ravikumar P, Das D, Bhattacharjee K. A comparative study of pulmonary involvement in patients with rheumatoid arthritis. J. Evolution Med. Dent. Sci. 2017;6(4):296-300,
  19. Nermeen Samy, Haitham Salah, Rasha M. Hammoda, Rheumatoid arthritis patients with interstitial lung disease: Clinical, radiological and laboratory characteristics, The Egyptian Rheumatologist 43 (2021) 29–34.